Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12280124
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof
granted -
US 12280140
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted -
US 12280057
Vasoactive topical compound to affect tissue blood flow, reduce tissue necrosis and promote healing
granted -
US 12280089
Dry powder formulation of caveolin-1 peptides and methods of use thereof
granted -
US 12280122
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
US 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
granted -
US 12280055
Combination therapies
granted -
US 12279630
Treatment and prevention of seed allergies
granted -
US 12280113
Ras inhibitors
granted -
US 12280120
Tumor-specific cleavable linkers
granted -
US 12281073
Substituted piperidine compound and use thereof
granted -
US 12281021
System and method for making boron oxide nanoparticles
granted -
US 2025120959
NEW FORMULATIONS OF PITOLISANT AND METHODS OF USE
granted -
WO 2025077836
LIPIDES IONISABLES ET NANOPARTICULES LIPIDIQUES POUR ADMINISTRATION D'ARN
granted -
WO 2025078995
COMPOSÉS DE 6-(PYRIMIDIN-4-YL)QUINOLÉINE SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE KINASE DÉPENDANTE DE LA CYCLINE
granted -
TW 202515875
Solid forms comprising a B-RAF kinase dimer inhibitor, methods of preparation, and uses therefor
granted -
TW 202515903
Anti-PD-1-based treatment before and after surgery
granted -
US 12275964
Variant type V CRISPR/Cas effector polypeptides and methods of use thereof
granted -
US 12275937
Stereospecific linkages in RNA editing oligonucleotides
granted -
US 12275957
Next generation designer liver organoids and their methods of preparation and use
granted -
US 12275966
Genetically engineered cells
granted -
US 12275955
Combining iPSC derived effector cell types for immunotherapy use
granted -
US 12275684
Methods for making and using endoxifen
granted -
US 12275685
Oligo-benzamide analogs and their use in cancer treatment
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.